Medicare Enrolled
Dr. Matthew Tobin, MD
Urology Physician · Neptune, NJ
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Tobin from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Tobin?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Tobin
Dr. Matthew Tobin is an urology physician in Neptune, NJ, with 20 years of NPI registration. Based on federal Medicare data, Dr. Tobin performed 15,259 Medicare services across 5,278 unique beneficiaries.
Between the years covered by Open Payments, Dr. Tobin received a total of $2,182 from 44 pharmaceutical and/or device companies across 121 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in urology physician. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Tobin is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice
▲ Top 4% volume in NJ
$2,182 industry payments
Medicare Practice Summary
Medicare Utilization ↗15,259
Medicare services
Top 4% in NJ for urology physician
5,278
Unique beneficiaries
$52
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~763 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Infectious disease DNA/RNA test A laboratory test that uses a specific technique to detect the genetic material of an organism. This method amplifies the target DNA or RNA to identify the presence of the organism. |
3,172 | $34 | $100 |
| Genetic analysis to identify organisms A laboratory test that uses genetic analysis and an amplified probe technique to identify specific organisms. |
2,928 | $34 | $100 |
| Automated urinalysis An automated laboratory test performed on a urine sample to analyze its chemical and physical properties. The procedure uses machinery to detect various substances and cells within the urine. |
1,953 | $2 | $12 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
1,939 | $100 | $225 |
| Bladder ultrasound after voiding An ultrasound scan performed after urination to measure the amount of urine remaining in the bladder. |
745 | $9 | $50 |
| Yeast/candida DNA test A laboratory test that uses an amplified probe technique to detect the presence of Candida species, a type of yeast, in a patient sample. |
502 | $34 | $100 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
415 | $74 | $175 |
| Leuprolide acetate (for depot suspension), 7.5 mg | 399 | $126 | $500 |
| Telephone medical discussion, 21-30 minutes A telephone conversation with a physician lasting between 21 and 30 minutes. This code covers the time spent discussing medical matters over the phone. |
389 | $99 | $250 |
| Subcutaneous or intramuscular chemotherapy injection This procedure involves administering anti-cancer hormonal medication through an injection into the tissue under the skin or into a muscle. |
333 | $27 | $99 |
| VRE nucleic acid detection test A laboratory test that uses amplified probe techniques to detect vancomycin-resistant Enterococcus (VRE) DNA in a patient sample. |
251 | $34 | $100 |
| Staphylococcus aureus DNA test A laboratory test that uses DNA amplification to detect the presence of Staphylococcus aureus bacteria in a sample. |
251 | $34 | $100 |
| MRSA nucleic acid detection test A laboratory test that uses amplified probe techniques to detect the genetic material of methicillin-resistant Staphylococcus aureus (MRSA) bacteria. |
251 | $34 | $100 |
| Nucleic acid test for multiple organisms A laboratory test that uses amplified probe techniques to detect the genetic material of multiple organisms in a sample. |
251 | $69 | $200 |
| Electronic assessment of bladder emptying A test that uses electronic monitoring to evaluate how well the bladder empties urine. |
201 | $10 | $196 |
| Telephone medical discussion, 11-20 minutes A phone conversation with a physician lasting between 11 and 20 minutes. |
200 | $72 | $200 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
163 | $130 | $334 |
| Cystourethroscopy A diagnostic exam of the bladder and urethra using an endoscope to visually inspect the urinary tract. |
154 | $213 | $515 |
| Shock wave crushing of kidney stones A procedure that uses shock waves to break kidney stones into smaller pieces so they can pass more easily from the body. |
98 | $484 | $1,305 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
97 | $67 | $152 |
| Simple insertion of temporary bladder tube A procedure to place a temporary tube into the bladder. This allows for the drainage of urine from the bladder. |
87 | $52 | $212 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
84 | $146 | $412 |
| Complex urodynamic pressure flow study A test that measures the pressure of urine flow in the bladder during voiding to evaluate how well the bladder and urethra are functioning. |
50 | $315 | $500 |
| Abdominal device insertion with pressure and urine flow study A procedure involving the placement of a device into the abdomen, accompanied by a study to measure pressure and urine flow rate. |
50 | $175 | $461 |
| Non-needle muscle activity measurement of bladder and bowel openings This procedure measures and records the electrical activity of muscles at the bladder and bowel openings without using needles. |
49 | $26 | $513 |
| Prostate gland biopsy A procedure to remove small samples of tissue from the prostate gland for laboratory examination. |
45 | $103 | $500 |
| Transrectal ultrasound of the pelvis An ultrasound imaging procedure where a probe is inserted into the rectum to visualize pelvic structures. |
44 | $26 | $81 |
| Ultrasound guidance for needle placement Use of ultrasound imaging to guide the precise placement of a needle during a medical procedure. |
43 | $25 | $78 |
| Complicated insertion of bladder tube | 34 | $133 | $359 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
30 | $146 | $293 |
| Imaging of urinary tract with contrast An imaging test of the urinary tract performed after a contrast agent is injected to enhance visibility of the structures. |
21 | $21 | $43 |
| Laser vaporization of prostate A procedure that uses a laser to remove excess prostate tissue through an endoscope. The process includes controlling any bleeding that occurs during the treatment. |
18 | $592 | $6,458 |
| Endoscopic removal of foreign body, stone, or stent from urethra or bladder A procedure to remove a foreign object, stone, or stent from the urethra or bladder using an endoscope. The endoscope is a thin tube with a camera inserted into the urinary tract to locate and extract the item. |
12 | $284 | $750 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
0.1% high complexity
8.1% medium
91.9% routine
Industry Payment Transparency
Open Payments through 2024 ↗$2,182
Total received (2018-2024)
Avg $312/year across 7 years
Bottom 49% in NJ for urology physician
44
Companies
121
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$1,928 (88.4%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$253 (11.6%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$152
2023
$193
2022
$487
2021
$285
2020
$163
2019
$414
2018
$487
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
PROGENICS PHARMACEUTICALS, INC.
$29
COLOPLAST CORP
$21
UROGEN PHARMA, INC.
$16
Telix Pharmaceuticals
$15
DENTSPLY IH AB
$15
Teleflex LLC
$15
ABBVIE INC.
$14
Axonics, Inc.
$14
Tolmar, Inc.
$13
Top 3 companies account for 43.4% of 2024 payments
All-time payments by company (2018-2024) ›
Antares Pharma, Inc.
$358
Astellas Pharma US Inc
$280
Medtronic USA, Inc.
$134
Myovant Sciences Inc.
$125
Janssen Biotech, Inc.
$98
Medtronic, Inc.
$92
TOLMAR Pharmaceuticals, Inc.
$85
Coloplast Corp
$77
Avadel Specialty Pharmaceuticals, LLC
$72
Axonics, Inc.
$71
180 Medical, Inc.
$70
Teleflex LLC
$56
AbbVie Inc.
$43
PROCEPT BioRobotics Corporation
$36
UroGen Pharma, Inc.
$29
Accord Healthcare, Inc.
$29
PROGENICS PHARMACEUTICALS, INC.
$29
Blue Earth Diagnostics Limited
$28
Boston Scientific Corporation
$28
Kowa Pharmaceuticals America, Inc.
$26
Acerus Pharmaceuticals Corporation
$26
C. R. Bard, Inc. & Subsidiaries
$26
Aytu BioScience, Inc
$25
AbbVie, Inc.
$24
Bayer HealthCare Pharmaceuticals Inc.
$23
COLOPLAST CORP
$21
Clarus Therapeutics Inc.
$19
DENTSPLY IH Inc.
$19
BOSTON SCIENTIFIC CORPORATION
$18
E.R. Squibb & Sons, L.L.C.
$17
UROGEN PHARMA, INC.
$16
Pacira Pharmaceuticals Incorporated
$15
Bayer Healthcare Pharmaceuticals Inc.
$15
Telix Pharmaceuticals
$15
Merck Sharp & Dohme LLC
$15
DENTSPLY IH AB
$15
Olympus America Inc.
$14
ABBVIE INC.
$14
Photocure Inc
$14
Tolmar, Inc.
$13
Dendreon Pharmaceuticals LLC
$12
NeoTract Inc.
$12
Retrophin, Inc.
$12
Allergan, Inc.
$12
Top 3 companies account for 35.4% of all-time payments
Associated products mentioned in payments ›
(815) Thiola · Androgel · AquaBeam Robotic System · Axonics · Axumin · BOTOX · Bulkamid · CAMCEVI · CEREC · CONTINENCE CARE · CYSTO-NEPHRO VIDEOSCOPE · CYSVIEW · ELIGARD · ERLEADA · Erleada · Exparel · ILLUCCIX · INTERSTIM · JATENZO · JELMYTO · KEYTRUDA · LITHOVUE · LOFRIC · LUPRON DEPOT · MYRBETRIQ · NOCDURNA · Natesto · Noctiva · Nubeqa · OPDIVO · ORGOVYX · OTREXUP · Otrexup · PROVENGE · PYLARIFY · Porges Coloplast · PureWick Female External Catheter · SOLESTA · SPEEDICATH · Seglentis · SpaceOAR VUE System - 10mL · SpeediCath · UROLIFT · UroLift · UroLift System · VESICARE · XTANDI · XYOSTED · ZYTIGA
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (88%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Urology physicians within 10 mi
57
Per 100K population
8.9
County median income
$122,727
Nearest hospital
MONMOUTH MEDICAL CENTER
7.4 mi
7.4 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Tobin is a clinical cardiology specialist, with above-average Medicare volume (top 4% in NJ), with low-engagement industry engagement, with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Tobin experienced with infectious disease dna/rna test?
Based on Medicare claims data, Dr. Tobin performed 3,172 infectious disease dna/rna test services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Tobin receive payments from pharmaceutical companies?
Yes. Dr. Tobin received a total of $2,182 from 44 companies across 121 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Tobin's costs compare to other urology physicians in Neptune?
Dr. Tobin's average Medicare payment per service is $52. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Tobin) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Urology Physicians in Neptune
Browse urology physicians in Neptune ranked by procedure volume and transparency data.
Highest volume
Top Urology Physicians in NJ
Urology physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Urology Physicians in NJ
Which NJ urology physicians receive the most from drug and device companies.
By company
Antares Pharma, Inc. Payments to Doctors
See all physicians who received payments from Antares Pharma, Inc.
By company
Astellas Pharma US Inc Payments to Doctors
See all physicians who received payments from Astellas Pharma US Inc.
By company
Medtronic USA, Inc. Payments to Doctors
See all physicians who received payments from Medtronic USA, Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology